28 -1 (25/1) 2019 — Kim O. V., Abdujabarov Z. M., — THE PREVALENCE OF OPPORTUNISTIC INFECTIONS AMONG HIV-INFECTED CHILDREN

THE PREVALENCE OF OPPORTUNISTIC INFECTIONS AMONG HIV-INFECTED CHILDREN

Kim O. V., Tashkent Institute of advanced medical education.

Abdujabarov Z. M., Tashkent Institute of advanced medical education.

Shamsiev F. S. Tashkent Institute of advanced medical education.

Resume

A prospective cohort study and a case-control (longitudinal) study were conducted in the Department of children with immunodeficiency States. All HIV-infected children were randomized by age, pathway of infection, stage of disease, severity of immunosuppression and virus replication activity.

High titers to viruses (virus herpes simplex-1, cytomegalovirus) and bacteria (Chlamydia trachomatis, Mycoplasma pneumonia, Ureaplasma urealyticum) were detected.

The spectrum  of OI in children with   HIV / AIDS is characterized by an “iceberg”   type of carrier and is Determined by age and the unfavorable epidemiological situation, especially in relation to socially significant diseases (TB), and also proves the feasibility of developing strategies aimed at their earliest detection and prevention, including vaccination against diseases, the probability of infection which is increased in immunocompromised patients.

Key words: HIV infection, children, prevalence, opportunistic infection.

First page

103

Last page

107

For citation: Kim O. V., Abdujabarov Z. M., Shamsiev F. S. The prevalence of opportunistic infections among hiv-infected children//New Day in Medicine 1(25)2019 103-107 https://cutt.ly/4bFuTdQ

List of References

1. Атабеков Н.С. Ситуация по ВИЧ-инфекции в Узбекистане // Сборник материалов научно-практической конференции “Со­временные подходы! в диагностике, профилактике и лечении ВИЧ-инфекции”. – Ташкент, 1-2 декабря 2010. – С.12-13.
2. Бартлетт Д., Галлант Дж., Фам П. Клинические аспекты ВИЧ- инфекции. – М.: Р. Валент., 2010. – 490 с.
3. Вартанян Ф.Е., Шаховский К.П. Туберкулез, ассоциирован­ный с ВИЧ-инфекцией, в странах мира // Эпидемиология и инфекционные болезни. – 2007. – № 4. – С.42-44.
4. Залялиева М.В. Генетические и иммунологические особеннос­ти ВИЧ-1 инфекции в Узбекистане / М.В. Залялиева, Р.М. Ру- зыбакиев. – Т.: O’zbekiston milliy ensiklopediyasi, 2010. – 112 с.
5. Камилов А.И., Субханова Н.Р., Агзамходжаева Н.С. Факторы риска и особенности течения ВИЧ-инфекции у детей. Педи­атрия, Ташкент. 2006. № 1. С.64-68.
6. Петрова А.Г., Смирнова С.В., Шугаева С.Н. Москалева Е.В. Клинико-иммунологические особенности туберкулеза у де­тей с перинатальной ВИЧ-инфекцией//Сибирский медицин­ский журнал. – 2008. – Том 23. – № 3. -С. 26-30.
7. Покровский В.В. Организация фтизиатрической помощи / В. В. Покровский, О. П. Фролова, А. В. Кравченко. – М., 2002. – 39 с.
8. Berenguer J et al. Characteristics and outcomes of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. Apr. 1, 2008; 47: 422 – 428.
9. Coovadia A. et al. Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor Based Viral Suppression: A Randomized Controlled Trial. JAMA. 2010; 304(10):1082-1090.
10. Puls R. et al. Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment-Naive, HIV-Infected Subjects: Week 48 Data from the Altair Study. Clin Infect Dis. 2010 Oct 1; 51(7):855-64.
11. Buchacz K. et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: A cohort study. AIDS 2010 Jun 19; 24:1549.